ReviewInnovation (Cambridge (Mass.))2023

First clinical study of germline-targeting strategy: One step closer to a successful bnAb-based HIV vaccine.

Caijun Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.